Drawing for MOVABLY

USPTO serial 90449012

MOVABLY

Reviewed by CopyMark Law Group

Reg. 8005135Status 700Registered
Filing date
Status date
Registration date
Oct 28, 2025
Examiner
PARKER, JUSTINE D
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MOVABLY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brendan M. Shortell

Brendan M. Shortell Lambert Shortell & Connaughton100 Franklin Street, Suite 903Boston, MA 02110United States

Goods and services

ClassDescriptionStatusFirst use
020Chairs; Office chairs; Reclining chairsACTIVESep 13, 2024
042Platform as a service (PAAS) featuring computer software platforms for intelligent analytics in the medical field; Software as a service (SAAS) services featuring software for digital health services, real-time feedback and tracking, personalized exercise therapy, one-on-one digital health coaching, providing information in the fields of health care, medical services, pain treatment, and wellness, facilitating communication among doctors, medical professionals, medical care providers, and patients; Providing a web hosting platform for intelligent analytics in the medical fieldACTIVESep 13, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 28, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 28, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 7, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 7, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Oct 7, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Oct 7, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 7, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 7, 2025SNEASU-EXAMINER'S AMENDMENT WRITTEN—
May 12, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
May 12, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Feb 12, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2025CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 17, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 17, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 7, 2024IUAFUSE AMENDMENT FILED—
Oct 7, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 9, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 8, 2024EX5GSOU EXTENSION 5 GRANTED—
Apr 8, 2024EXT5SOU EXTENSION 5 FILED—
Apr 8, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 11, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 9, 2023EX4GSOU EXTENSION 4 GRANTED—
Oct 9, 2023EXT4SOU EXTENSION 4 FILED—
Oct 9, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 5, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 5, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 5, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 5, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 11, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 7, 2023EX3GSOU EXTENSION 3 GRANTED—
Apr 7, 2023EXT3SOU EXTENSION 3 FILED—
Apr 7, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 6, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 4, 2022EX2GSOU EXTENSION 2 GRANTED—
Oct 4, 2022EXT2SOU EXTENSION 2 FILED—
Oct 4, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 26, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 25, 2022EX1GSOU EXTENSION 1 GRANTED—
May 25, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 30, 2022NREVNOTICE OF REVIVAL - E-MAILED—
Apr 29, 2022TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Apr 29, 2022PETGPETITION TO REVIVE-GRANTED—
Apr 29, 2022PROATEAS PETITION TO REVIVE RECEIVED—
Apr 19, 2022EXT1SOU EXTENSION 1 FILED—
Oct 19, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 24, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 24, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 4, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 16, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 13, 2021DOCKASSIGNED TO EXAMINER—
Apr 4, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 8, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance